European Journal of Cancer
Volume 44, Issue 1 , Pages 8-11, January 2008

Recommended changes to oncology clinical trial design: Revolution or evolution?

  • Mark J. Ratain

      Affiliations

    • University of Chicago, Chicago, IL, USA
    • Corresponding Author InformationCorresponding author: Tel.: +1 773 702 4400; fax: +1 773 702 3969.
    • ,
  • Rachel W. Humphrey

      Affiliations

    • Bristol-Myers Squibb, Wallingford, CT, USA
    • ,
  • Gary B. Gordon

      Affiliations

    • Abbott Laboratories, Abbott Park, IL, USA
    • ,
  • Gwen Fyfe

      Affiliations

    • Genentech, San Francisco, CA, USA
    • ,
  • Peter C. Adamson

      Affiliations

    • Children’s Hospital of Pennsylvania, Philadelphia, PA, USA
    • ,
  • Thomas R. Fleming

      Affiliations

    • University of Washington, Seattle, WA, USA
    • ,
  • Walter M. Stadler

      Affiliations

    • University of Chicago, Chicago, IL, USA
    • ,
  • Donald A. Berry

      Affiliations

    • MD Anderson Cancer Center, Houston, TX, USA
    • ,
  • Carl C. Peck

      Affiliations

    • University of California, San Francisco, CA, USA

Received 10 September 2007; accepted 19 September 2007. published online 05 November 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(07)00737-X

doi:10.1016/j.ejca.2007.09.011

European Journal of Cancer
Volume 44, Issue 1 , Pages 8-11, January 2008

Article Tools